DLA seeks a national requirements contract for Epinephrine 0.3 MG/0.3 ML auto-injectors (2S, 2-count bottles) through an unrestricted, fully competitive acquisition under FAR Part 12 for commercial items. The resulting firm-fixed-price, requirements-type contract will have a one-year base and four one-year options and establish a national supply source for DoD, VA, Indian Health Service, and Bureau of Prisons purchases through DLA and VA prime vendor programs. Annual usage estimates will be provided in the solicitation’s Schedule of Supplies. The solicitation is expected to be posted on DIBBS and SAM.gov, with the current solicitation date in October 2026. Interested parties may contact Jeremy Brown at 445-737-5419 or jeremy.brown@dla.mil with questions.

The Defense Logistics Agency is seeking a national requirements contract for Epinephrine 0.3 MG/0.3 ML auto-injectors, 2S in 2-count bottles. The acquisition is unrestricted and fully competitive, structured as a firm-fixed-price, requirements-type contract with a one-year base plus four one-year option periods. The resulting national supply source will support Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through DLA and VA prime vendor programs. It is a commercial item procurement under FAR Part 12, and the solicitation will be posted on DIBBS and Sam.Gov. The current solicitation date is October 2026; interested parties may contact Jeremy Brown at (445) 737-5419 or jeremy.brown@dla.mil for questions.